PACS
PACS Group, Inc. · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +0.5% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 92 | +6 | 32.30M | $1.38B | +8 | −2 |
| Q1 2026 | 89 | +3 | 29.37M | $943.57M | +9 | −6 |
| Q4 2025 | 86 | +1 | 29.12M | $1.12B | +1 | n/a |
| Q3 2025 | 18 | +1 | 20.54M | $282.02M | +1 | −1 |
| Q2 2025 | 15 | 0 | 21.01M | $271.39M | +2 | −2 |
| Q1 2025 | 12 | +1 | 9.60M | $107.95M | +2 | −1 |
| Q4 2024 | 11 | -2 | 10.08M | $132.14M | +2 | −4 |
| Q3 2024 | 12 | +1 | 9.71M | $388.06M | +1 | n/a |
| Q2 2024 | 11 | n/a | 6.66M | $196.56M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.51M | +7.8% | $84.14M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 2 | The Vanguard Group ✦ (passive) | 3.85M | n/a | $49.80M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (passive) | 3.81M | n/a | $49.27M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 4 | Fidelity (FMR) ✦ | 3.63M | n/a | $46.87M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 5 | Geode Capital Management ✦ (passive) | 952.36K | +11.5% | $12.31M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (passive) | 934.82K | -0.5% | $12.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 354.46K | +480.4% | $4.58M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Marshall Wace ✦ | 225.37K | +4.9% | $2.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 205.22K | -40.2% | $2.65M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Millennium Management ✦ | 174.92K | -79.6% | $2.26M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 162.70K | New | $2.10M | 0.0% | New | 1 | SEC ↗ ×5 |
| 12 | Renaissance Technologies ✦ | 103.90K | New | $1.34M | 0.0% | New | 1 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 45.44K | 0.0% | $587,136 | 0.0% | Held | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 22.03K | +29.2% | $285,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Norges Bank ✦ (passive) | 15.52K | 0.0% | $200,570 | 0.0% | Held | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| AQR Capital Management | $2.10M | 0.0% |
| Renaissance Technologies | $1.34M | 0.0% |
Exited
| Point72 Asset Management | $2.01M | was 0.0% |
| D. E. Shaw & Co. | $372,078 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 9.10K shares, $292 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director, 10% owner · 8.46K sh · $402,876
Officer, Director, 10% owner · 4.63K sh · $211,319
Officer, Director, 10% owner · 3.06K sh · $147,298
Officer, Director, 10% owner · 77.54K sh · $3.68M
Officer, Director, 10% owner · 24.80K sh · $1.16M
Officer · 40.00K sh · $1.78M
Officer, Director, 10% owner · 232 sh · $10,440
Officer, Director, 10% owner · 717 sh · $30,458
Officer, Director, 10% owner · 7.22K sh · $315,146
Officer, Director, 10% owner · 28.75K sh · $1.24M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology